LipL1

PF3D7_1314600 (LipL1) is a mitochondrial ATP-dependent lipoate-protein ligase of P. falciparum that drives lipoylation of mitochondrial 2-oxoacid dehydrogenase machinery using lipoate acquired by scavenging rather than de novo synthesis (PMID:15225307, PMID:17244193). It localizes to the parasite mitochondrion and functions as a genuine lipoate ligase, restoring lipoate scavenging in lipoylation-deficient bacteria; chemical inhibition of LipL1 by 8-bromo-octanoate arrests intraerythrocytic growth and blocks lipoate incorporation into parasite proteins, an effect reversed by exogenous lipoate (PMID:15225307, PMID:17244193). LipL1-mediated scavenging feeds mitochondrial, but not apicoplast, lipoylation, establishing these as non-redundant pathways (PMID:17244193). Mechanistically LipL1 operates as a redox switch: under less reducing conditions it acts as a canonical ligase that lipoylates the glycine cleavage system H-protein, whereas under strongly reducing conditions it acts as a lipoate-activating enzyme that cooperates with the lipoyltransferase LipL2 to lipoylate the E2 subunits of branched-chain 2-oxoacid dehydrogenase (BCDH) and 2-oxoglutarate dehydrogenase (KDH) (PMID:25116855, PMID:28836704). A crystal structure of a LipL1 deletion construct bound to lipoate places it in the biotin/lipoate A/B protein ligase family (PMID:28543853). LipL1 is essential for asexual blood-stage survival: gene disruption repeatedly failed in P. falciparum and knockouts could not be cloned in P. berghei, though conditional knockdown in P. berghei can be partially compensated by upregulation of lplA2 (PMID:18069893, PMID:19434237, PMID:28655332).

1. 2004 Medium

   Establishing where LipL1 acts and whether it is a bona fide lipoate ligase was the first step in placing lipoate metabolism in the parasite; the finding localized it to the mitochondrion and confirmed catalytic function.

   Evidence GFP fusion of N-terminal targeting sequence in intraerythrocytic parasites plus complementation of lipA/lipB-deficient bacteria

   PMID:15225307

   Open questions at the time

   • Full-length localization not shown, only N-terminal sequence
   • Endogenous substrates not identified
   • Enzymatic mechanism not characterized
2. 2007 Medium

   Whether LipL1 activity is required for parasite growth and which lipoate source it uses was unknown; chemical inhibition with rescue and radiolabelled tracing showed LipL1 scavenges lipoate to lipoylate mitochondrial proteins and that this is growth-critical, distinct from apicoplast lipoylation.

   Evidence Bacterial complementation, radiolabelled lipoate incorporation, 8-bromo-octanoate inhibition with lipoate rescue, anti-PDH E2 immunoblot

   PMID:17244193 PMID:18069893

   Open questions at the time

   • Specific mitochondrial substrates not yet resolved
   • Inhibitor selectivity for LipL1 versus other enzymes not fully excluded
   • Non-redundancy with LplA2 inferred, not directly demonstrated
3. 2009 Medium

   Genetic essentiality was untested; failed disruption in P. falciparum and inability to clone knockouts in P. berghei established LipL1 as required for erythrocytic-stage growth in vitro and in vivo.

   Evidence Knockout/knock-in attempts in P. berghei and repeated failed gene disruption in P. falciparum

   PMID:19434237

   Open questions at the time

   • No conditional system to confirm essentiality directly
   • Stage-specific requirement beyond blood stage not addressed
4. 2014 High

   The substrate range and cofactor requirements were unresolved; in vitro reconstitution showed LipL1 alone lipoylates H-protein but requires LipL2 to lipoylate BCDH and KDH E2 subunits, and that substrate selection is redox-dependent.

   Evidence In vitro lipoylation assays under varied redox conditions, GFP-fusion substrate localization, reconstitution with purified LipL1 and LipL2

   PMID:25116855

   Open questions at the time

   • Physiological redox state in vivo not measured
   • Structural basis of the LipL1–LipL2 cooperation not defined
5. 2017 High

   How one enzyme could serve two substrate classes was open; biochemical dissection defined LipL1 as a redox switch that toggles between canonical ligase and lipoate-activating enzyme modes, and a lipoate-bound crystal structure assigned it to the biotin/lipoate A/B ligase family.

   Evidence In vitro lipoylation assays with reduced versus oxidised lipoate, activity assays distinguishing LipL1 and LipL2, and X-ray crystallography of PfLipL1Δ243-279 with orthogonal functional validation

   PMID:28543853 PMID:28836704

   Open questions at the time

   • In vivo trigger controlling the redox switch not identified
   • Structure of the LipL1–LipL2 complex or full-length LipL1 not solved
6. 2017 Medium

   Whether LipL1 loss could be tolerated was tested by conditional knockdown, which caused severe early growth impairment in P. berghei with late recovery coinciding with lplA2 upregulation, indicating a compensatory alternative pathway.

   Evidence ATc-inducible conditional knockout in P. berghei, in vivo parasitemia and in vitro growth assays, RT-PCR for lplA1 and lplA2

   PMID:28655332

   Open questions at the time

   • Compensation inferred from mRNA, not confirmed at protein or activity level
   • P. falciparum conditional confirmation lacking

• What physiological signal sets the mitochondrial redox state that selects between LipL1's ligase and activating-enzyme modes, and the structural mechanism of LipL1–LipL2 cooperation, remain unresolved.
• No in vivo measurement of the redox trigger
• No structure of the LipL1–LipL2 assembly
• Compensation by LplA2 not validated at the protein level